Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and approve 1. To consider and approve ....
AHCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anlon Healthcare has informed BSE and NSE that its Board of Directors will meet on Tuesday, November 11, 2025, at the registered office in Rajkot, Gujarat. The key item on the agenda is to consider and approve the Unaudited Standalone Financial Results along with the Limited Review Report for the quarter and half year ended September 30, 2025 (i.e., Q2 and H1 of FY26). The filing also includes a standard catch-all item for any other business with the Chair's permission. No actual financial numbers have been disclosed in this filing — it is a routine pre-results intimation made under SEBI Listing Regulations 29 and 33. The company is listed on both BSE (Scrip Code: 544497) and NSE (Scrip Code: AHCL).
This is a routine regulatory filing and carries no direct impact on the stock. Investors should watch for the actual Q2/H1 FY26 results announcement, which is expected on or shortly after November 11, 2025, for insights into the company's revenue, profitability, and margin trends.